788 Results

People

  1. Offit
    Offit
  2. Robson
    Robson
  3. Joseph
    Joseph
  4. Stadler
    Stadler
  5. Mandelker
    Mandelker
  6. Kemel
    Kemel
  7. Kauff
    Kauff
  8. Berger
    Berger
  9. Walsh
    Walsh
  10. Carlo
    Carlo

Groups

  1. Clinical Genetics Service (788)
  2. Department of Medicine (788)
  3. GSK Faculty (788)
  4. Population Sciences Research Program (788)
  5. Solid Tumor Oncology Division (788)
  6. Survivorship Research (788)
  7. Breast Medicine Service (300)
  8. Surgery (200)
  9. Department of Pathology and Laboratory Medicine (199)
  10. Center for Pancreatic Cancer Research (183)
  1. "Kenneth Offit"
Formats
  1. Journal Article (544)
  2. Meeting Abstract (216)
  3. Review (9)
  4. Book Section (7)
  5. Conference Paper (3)
  6. Guidelines (3)
  7. Research Letter (3)
  8. Correspondence (2)
  9. Book Whole (1)
Groups
  1. Clinical Genetics Service (788)
  2. Department of Medicine (788)
  3. GSK Faculty (788)
  4. Population Sciences Research Program (788)
  5. Solid Tumor Oncology Division (788)
  6. Survivorship Research (788)

More Groups

People
  1. Kenneth Offit (788)
  2. Mark Robson (280)
  3. Vijai Joseph (193)
  4. Zsofia Stadler (165)
  5. Diana Mandelker (86)
  6. Michael Walsh (81)

More People

Years
  1. 2025 (4)
  2. 2024 (18)
  3. 2023 (40)
  4. 2022 (35)
  5. 2021 (39)
  6. 2020 (48)

More Years

Publications
  1. Journal of Clinical Oncology (138)
  2. Cancer Research (46)
  3. Blood (34)
  4. American Journal of Human Genetics (32)
  5. Genetics in Medicine (25)
  6. Nature Genetics (25)

More Publications

Publishers
  1. American Society of Clinical Oncology (153)
  2. Nature Publishing Group (109)
  3. American Association for Cancer Research (84)
  4. Springer (44)
  5. Elsevier Inc. (37)
  6. Oxford University Press (37)

More Publishers

Results (788)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    Chen, Y. W.; Liu, L.; Cheng, Y.; Araneta, A.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Runcie, K.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
    Journal Article

    Mitchell, J.; Camacho, N.; Shea, P.; Stopsack, K. H.; Joseph, V.; Burren, O. S.; Dhindsa, R. S.; Nag, A.; Berchuck, J. E.; O'Neill, A.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett's esophagus and esophageal adenocarcinoma
    Journal Article

    Yan, L.; He, Q.; Verma, S. P.; Zhang, X.; Giel, A. S.; Maj, C.; Graz, K.; Naderi, E.; Chen, J.; Ali, M. W.; more...
    Human Genetics and Genomics Advances (2025)

    Fulltext@MSK | Save
  • Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer
    Journal Article

    Stopsack, K. H.; Vijai, J.; Conry, M.; Berchuck, J. E.; Kemel, Y.; Vasselman, S. E.; Freeman, D. A.; Lee, G. S. M.; Mandelker, D.; Solit, D. B.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Characterising the contribution of rare protein-coding variants to prostate cancer risk and severity in 36,866 cases
    Meeting Abstract

    Mitchell, J.; Camacho, N.; Shea, P. R.; Stopsack, K.; Joseph, V.; Burren, O.; Penney, K.; Berchuck, J.; Wang, Q. L.; Goldstein, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Genetic drivers and cellular selection of female mosaic X chromosome loss
    Journal Article

    Liu, A.; Genovese, G.; Zhao, Y.; Pirinen, M.; Zekavat, S. M.; Kentistou, K. A.; Yang, Z.; Yu, K.; Vlasschaert, C.; Liu, X.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational cohort study
    Journal Article

    Shickh, S.; Mighton, C.; Clausen, M.; Sam, J.; Hirjikaka, D.; Reble, E.; Graham, T.; Panchal, S.; Eisen, A.; Elser, C.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Polygenic score distribution differences across European ancestry populations: Implications for breast cancer risk prediction
    Journal Article

    Yiangou, K.; Mavaddat, N.; Dennis, J.; Zanti, M.; Wang, Q.; Bolla, M. K.; Abubakar, M.; Ahearn, T. U.; Andrulis, I. L.; Anton-Culver, H.; more...
    Breast Cancer Research (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Wang, L.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save